This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aguilar, L.
Right arrow Articles by Dal-re, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aguilar, L.
Right arrow Articles by Dal-re, R.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, Jan 1996, 17-21, Vol 40, No. 1
Copyright © 1996 by the American Society for Microbiology. All rights reserved.

Ex vivo antibacterial properties of rufloxacin compared with those of norfloxacin in a study with healthy volunteers

L Aguilar, IP Balcabao, P Salva, M Martin, J Costa, J Prieto and R Dal-re
Medical Department, SmithKline Beecham Pharmaceuticals, Universidad Complutense, Madrid, Spain.

Twelve adult males participated in a randomized crossover phase I clinical trial comparing serum bactericidal titers (SBTs), urine bactericidal titers (UBTs), and urine killing rates (UKRs) against Escherichia coli ATCC 25922 and Staphylococcus aureus ATCC 29213, after the administration of single 400-mg doses of rufloxacin and norfloxacin at different times up to 72 h postdose. SBTs were significantly higher (P < 0.05) against E. coli from 8 to 48 h and against S. aureus from 4 to 24 h with rufloxacin. UBTs for E. coli were higher (P < 0.05) for norfloxacin at early sample times (0 to 8 h) but higher for rufloxacin (P < 0.05) at sample times from 16 h on for both E. coli and S. aureus. Similar UKRs were obtained for both quinolones for 0 to 2 h and 8 to 12 h, but the UKR was maintained for 72 h with rufloxacin. The high and sustained mean levels of rufloxacin in urine (> 35 micrograms/ml), median UBTs (> 32 for E. coli and 16 for S. aureus) and UKRs for E. coli suggest prolonged urine antibacterial activity (for at least 72 h) and its use as a single 400-mg dose in the treatment of uncomplicated cystitis.


This article has been cited by other articles:

  • Alou, L., Aguilar, L., Sevillano, D., Gimenez, M.-J., Cafini, F., Valero, E., Relano, M.-T., Prieto, J. (2006). Urine bactericidal activity against resistant Escherichia coli in an in vitro pharmacodynamic model simulating urine concentrations obtained after 2000/125 mg sustained-release co-amoxiclav and 400 mg norfloxacin administration. J Antimicrob Chemother 57: 714-719 [Abstract] [Full Text]  
  • García-Calvo, G., Parra, A., Aguilar, L., Ponte, C., Giménez, M. J., Carcas, A., Kinzig-Schippers, M., Soriano, F. (2001). Antibacterial Properties of Gemifloxacin and Trovafloxacin in Urine Ex Vivo: Phase I Study. Antimicrob. Agents Chemother. 45: 1876-1878 [Abstract] [Full Text]  
  • Naber, K. G., Theuretzbacher, U., Kinzig, M., Savov, O., Sörgel, F. (1998). Urinary Excretion and Bactericidal Activities of a Single Oral Dose of 400 Milligrams of Fleroxacin versus a Single Oral Dose of 800 Milligrams of Pefloxacin in Healthy Volunteers. Antimicrob. Agents Chemother. 42: 1659-1665 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»